{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:00:05Z","timestamp":1791932405214,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-13-1-0034"],"award-info":[{"award-number":["HDTRA1-13-1-0034"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI109711"],"award-info":[{"award-number":["U19 AI109711"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.celrep.2018.07.035","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T10:58:31Z","timestamp":1534244311000},"page":"1802-1815.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors"],"prefix":"10.1016","volume":"24","author":[{"given":"Natalia A.","family":"Kuzmina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Younan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlo","family":"Gilchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo I.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew I.","family":"Flyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp A.","family":"Ilinykh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndongala M.","family":"Lubaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palaniappan","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bukreyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2018.07.035_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.2016.1121814","article-title":"Paradoxical role of antibodies in dengue virus infections: Considerations for prophylactic vaccine development","volume":"15","author":"Acosta","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.celrep.2018.07.035_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/icb.2014.42","article-title":"HIV-specific antibody-dependent phagocytosis matures during HIV infection","volume":"92","author":"Ana-Sosa-Batiz","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.celrep.2018.07.035_bib3","doi-asserted-by":"crossref","first-page":"e0154461","DOI":"10.1371\/journal.pone.0154461","article-title":"Influenza-specific antibody-dependent phagocytosis","volume":"11","author":"Ana-Sosa-Batiz","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2018.07.035_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.humpath.2014.01.022","article-title":"Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar","volume":"45","author":"Aye","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.celrep.2018.07.035_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2018.07.035_bib6","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.1120453109","article-title":"Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography","volume":"109","author":"Bharat","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.07.035_bib7","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1128\/JVI.00220-10","article-title":"Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection","volume":"85","author":"Boonnak","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2018.07.035_bib9","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/cb300130k","article-title":"Revisiting the role of glycosylation in the structure of human IgG Fc","volume":"7","author":"Borrok","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.celrep.2018.07.035_bib10","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1172\/JCI24772","article-title":"Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions","volume":"115","author":"Boruchov","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2018.07.035_bib11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.immuni.2017.07.009","article-title":"Fc\u03b3 receptor function and the design of vaccination strategies","volume":"47","author":"Bournazos","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2018.07.035_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A\u00a0mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2018.07.035_bib13","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2018.07.035_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/femsre\/fuw010","article-title":"Neglected filoviruses","volume":"40","author":"Burk","year":"2016","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.celrep.2018.07.035_bib15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1586\/14787210.2015.1079127","article-title":"Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases","volume":"13","author":"Chan","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.celrep.2018.07.035_bib16","doi-asserted-by":"crossref","first-page":"e1004951","DOI":"10.1371\/journal.pcbi.1004951","article-title":"Modelling virus and antibody dynamics during dengue virus infection suggests a role for antibody in virus clearance","volume":"12","author":"Clapham","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.celrep.2018.07.035_bib17","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2018.07.035_bib18","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1128\/JVI.01490-15","article-title":"Mechanism of binding to ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies","volume":"89","author":"Davidson","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib19","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1128\/JVI.00425-08","article-title":"Cell adhesion promotes Ebola virus envelope glycoprotein-mediated binding and infection","volume":"82","author":"Dube","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.virol.2008.03.028","article-title":"Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever","volume":"376","author":"Durbin","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2018.07.035_bib21","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.07.035_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2018.07.035_bib23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jlb.49.6.556","article-title":"The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc gamma RII","volume":"49","author":"Fleit","year":"1991","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.celrep.2018.07.035_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/tra.12012","article-title":"Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans","volume":"14","author":"Flipse","year":"2013","journal-title":"Traffic"},{"key":"10.1016\/j.celrep.2018.07.035_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.cell.2015.01.031","article-title":"Mechanism of human antibody-mediated neutralization of Marburg virus","volume":"160","author":"Flyak","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2018.07.035_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2018.07.035_bib27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41564-018-0157-z","article-title":"Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region","volume":"3","author":"Flyak","year":"2018","journal-title":"Nat Microbiol."},{"key":"10.1016\/j.celrep.2018.07.035_bib28","doi-asserted-by":"crossref","first-page":"e1006139","DOI":"10.1371\/journal.ppat.1006139","article-title":"Fc\u03b3-receptor IIa-mediated Src signaling pathway is essential for the antibody-dependent enhancement of ebola virus infection","volume":"12","author":"Furuyama","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2018.07.035_bib29","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: Evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.celrep.2018.07.035_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fimmu.2014.00254","article-title":"Contribution of Human Fc\u03b3Rs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies","volume":"5","author":"Gillis","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2018.07.035_bib31","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1099\/0022-1317-66-9-1969","article-title":"Flavivirus infection enhancement in macrophages: An electron microscopic study of viral cellular entry","volume":"66","author":"Gollins","year":"1985","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib32","series-title":"Cold Spring Harbor Monograph Archive 28: Cellular Receptors for Animal Viruses","first-page":"493","article-title":"Antibody-dependent enhancement of infection: A\u00a0mechanism for indirect virus entry into cells","author":"Halstead","year":"1994"},{"key":"10.1016\/j.celrep.2018.07.035_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2018.07.035_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1084\/jem.146.1.218","article-title":"Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in\u00a0vitro infection","volume":"146","author":"Halstead","year":"1977","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2018.07.035_bib35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: Interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2018.07.035_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.07.035_bib37","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1128\/JVI.75.24.12161-12168.2001","article-title":"Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1","volume":"75","author":"Hezareh","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2016.01.005","article-title":"N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins","volume":"100","author":"Higel","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.celrep.2018.07.035_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrd2909","article-title":"Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond","volume":"11","author":"Hogarth","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2018.07.035_bib40","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1128\/JVI.00101-16","article-title":"Chimeric filoviruses for identification and characterization of monoclonal antibodies","volume":"90","author":"Ilinykh","year":"2016","journal-title":"J.\u00a0Virol."},{"issue":"Suppl 2","key":"10.1016\/j.celrep.2018.07.035_bib41","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1086\/520587","article-title":"Ebola hemorrhagic fever: Evaluation of passive immunotherapy in nonhuman primates","volume":"196","author":"Jahrling","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2018.07.035_bib42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.virol.2010.11.007","article-title":"Human\u00a0antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes","volume":"410","author":"Kou","year":"2011","journal-title":"Virology"},{"issue":"Suppl 1","key":"10.1016\/j.celrep.2018.07.035_bib43","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1086\/514321","article-title":"Clinical virology of Ebola hemorrhagic fever (EHF): Virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995","volume":"179","author":"Ksiazek","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.celrep.2018.07.035_bib44","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1086\/514294","article-title":"Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections","volume":"179","author":"Kudoyarova-Zubavichene","year":"1999","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2018.07.035_bib45","series-title":"Filoviruses","author":"Kuhn","year":"2008"},{"key":"10.1016\/j.celrep.2018.07.035_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.07.035_bib47","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.144.8.3183","article-title":"Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection","volume":"144","author":"Littaua","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2018.07.035_bib48","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/jps.24444","article-title":"Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins","volume":"104","author":"Liu","year":"2015","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.celrep.2018.07.035_bib49","doi-asserted-by":"crossref","first-page":"8440","DOI":"10.4049\/jimmunol.177.12.8440","article-title":"Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes","volume":"177","author":"Liu","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2018.07.035_bib50","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1128\/JVI.03316-12","article-title":"The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains","volume":"87","author":"Lubaki","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib51","doi-asserted-by":"crossref","first-page":"e1006031","DOI":"10.1371\/journal.ppat.1006031","article-title":"The Ebola interferon inhibiting domains attenuate and dysregulate cell-mediated immune responses","volume":"12","author":"Lubaki","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2018.07.035_bib52","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1128\/JVI.02695-12","article-title":"Ebola virus exploits a monocyte differentiation program to promote its entry","volume":"87","author":"Martinez","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib53","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/14760584.2016.1187566","article-title":"Ebola virus disease candidate vaccines under evaluation in clinical trials","volume":"15","author":"Martins","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.celrep.2018.07.035_bib54","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation","volume":"112","author":"McElroy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.07.035_bib55","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrmicro3524","article-title":"Filovirus pathogenesis and immune evasion: Insights from Ebola virus and Marburg virus","volume":"13","author":"Messaoudi","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2018.07.035_bib56","doi-asserted-by":"crossref","first-page":"e2600","DOI":"10.1371\/journal.pntd.0002600","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus","volume":"7","author":"Mire","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.celrep.2018.07.035_bib57","doi-asserted-by":"crossref","first-page":"eaai8711","DOI":"10.1126\/scitranslmed.aai8711","article-title":"Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody","volume":"9","author":"Mire","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2018.07.035_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1099\/0022-1317-68-1-91","article-title":"Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses","volume":"68","author":"Morens","year":"1987","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib59","doi-asserted-by":"crossref","first-page":"17182","DOI":"10.1073\/pnas.1414164111","article-title":"Structures of protective antibodies reveal sites of vulnerability on Ebola virus","volume":"111","author":"Murin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl 3","key":"10.1016\/j.celrep.2018.07.035_bib60","doi-asserted-by":"crossref","first-page":"S978","DOI":"10.1093\/infdis\/jir334","article-title":"Antibody-dependent enhancement of Marburg virus infection","volume":"204","author":"Nakayama","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2018.07.035_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2018.07.035_bib62","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.07.035_bib63","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2018.07.035_bib64","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1172\/JCI116790","article-title":"In the absence of other Fc receptors, Fc gamma RIIIA transmits a phagocytic signal that requires the cytoplasmic domain of its gamma subunit","volume":"92","author":"Park","year":"1993","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2018.07.035_bib65","doi-asserted-by":"crossref","first-page":"41537","DOI":"10.1038\/srep41537","article-title":"Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG","volume":"7","author":"Pyankov","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2018.07.035_bib66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.clim.2011.08.008","article-title":"Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies","volume":"141","author":"Qiu","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.celrep.2018.07.035_bib67","doi-asserted-by":"crossref","first-page":"138ra81","DOI":"10.1126\/scitranslmed.3003876","article-title":"Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2018.07.035_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.07.035_bib69","doi-asserted-by":"crossref","first-page":"329ra33","DOI":"10.1126\/scitranslmed.aad9875","article-title":"Two-mAb cocktail protects macaques against the Makona variant of Ebola virus","volume":"8","author":"Qiu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2018.07.035_bib70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2015.10.012","article-title":"Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection","volume":"124","author":"Ramadhany","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.celrep.2018.07.035_bib71","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/glycob\/cwv065","article-title":"Fc glycans of therapeutic antibodies as critical quality attributes","volume":"25","author":"Reusch","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.celrep.2018.07.035_bib72","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1128\/JVI.00792-06","article-title":"Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32)","volume":"80","author":"Rodrigo","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib73","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.07.035_bib74","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1128\/JVI.75.22.11025-11033.2001","article-title":"Infection and activation of monocytes by Marburg and Ebola viruses","volume":"75","author":"Str\u00f6her","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imr.12334","article-title":"The many faces of Fc\u03b3RI: Implications for therapeutic antibody function","volume":"268","author":"Swisher","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2018.07.035_bib76","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/JVI.75.5.2324-2330.2001","article-title":"Infectivity-enhancing antibodies to Ebola virus glycoprotein","volume":"75","author":"Takada","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2018.07.035_bib77","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1128\/JVI.77.13.7539-7544.2003","article-title":"Antibody-dependent enhancement of Ebola virus infection","volume":"77","author":"Takada","year":"2003","journal-title":"J.\u00a0Virol."},{"issue":"Suppl 2","key":"10.1016\/j.celrep.2018.07.035_bib78","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1086\/520581","article-title":"Epitopes required for antibody-dependent enhancement of Ebola virus infection","volume":"196","author":"Takada","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2018.07.035_bib79","doi-asserted-by":"crossref","first-page":"e1005817","DOI":"10.1371\/journal.ppat.1005817","article-title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses","volume":"12","author":"Tay","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2018.07.035_bib80","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0161-5890(01)00010-4","article-title":"Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation","volume":"37","author":"Thommesen","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.celrep.2018.07.035_bib81","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","article-title":"Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening","volume":"332","author":"Towner","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2018.07.035_bib82","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/viro.1995.0052","article-title":"GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases","volume":"214","author":"Volchkov","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2018.07.035_bib83","doi-asserted-by":"crossref","first-page":"e1003157","DOI":"10.1371\/journal.ppat.1003157","article-title":"Therapeutic efficacy of antibodies lacking Fc\u03b3 receptor binding against lethal dengue virus infection\u00a0is due to neutralizing potency and blocking of enhancing antibodies [corrected]","volume":"9","author":"Williams","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2018.07.035_bib84","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.celrep.2018.07.035_bib85","doi-asserted-by":"crossref","first-page":"20690","DOI":"10.1073\/pnas.1108360108","article-title":"Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant","volume":"108","author":"Zeitlin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124718311252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124718311252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:25:15Z","timestamp":1761906315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124718311252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2211124718311252"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2018.07.035","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2018.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors.","name":"copyright","label":"Copyright"}]}}